Menu

Bolt Biotherapeutics, Inc. BOLT

Full chart Compare
Set alert

Price alert · BOLT

All alert types
6.38 USD -0.12 (-1.85%)

At closeNov 5, 2026, 4:00 PM EST

6.36 -0.02 -0.31%

After hours · Nov 5, 4:00 PM ET

6.14 Day range 6.53
3.10 52-week range 7.78
YTD
+16.64%
1 year
+31.01%

Revenue & Expenses

Other Income → Expenses: $1.26MOther Operating Income → Expenses: $1.49MExpenses → Selling, General & Admin: $13.79MExpenses → Research & Development: $28.53MGross Profit → Expenses: $6.20MRevenue → Gross Profit: $6.20MRevenue → Cost of Revenue: $1.49MNet Loss → Expenses: $33.38MOther Income$1.26MOther Operating Income$1.49MGross Profit$6.20MNet Loss$33.38MCost of Revenue$1.49MExpenses$42.33MSelling, General & Admin$13.79MResearch & Development$28.53MRevenue$7.70M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BOLT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.70M7.69M7.88M5.73M1.26M
7.70M7.69M7.88M5.73M1.26M
-36.11M-73.05M-76.20M-90.32M-92.79M
-33.38M-63.12M-69.20M-88.10M-98.59M
-17.85-33.06-36.60-47.20-59.00
BOLT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
11.90M7.99M10.81M10.81M28.95M
56.75M99.63M159.78M227.81M307.72M
30.24M42.43M47.04M56.30M57.60M
22.96M25.21M20.22M22.61M24.36M
26.50M57.20M112.74M171.51M250.12M
BOLT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-39.85M-61.29M-69.53M-76.50M-57.07M
44.30M57.58M71.04M57.86M-232.20M
19.00K108.00K253.00K503.00K311.11M
891.00K107.00K-206.00K-1.95M-2.34M
4.47M-3.60M1.77M-18.14M21.84M